Latest Articles

Publication Date
Hormonal Dysregulation and Neuroinflammation in Endometriosis: Convergent Druggable Pathways.

Endometriosis is a chronic, estrogen-dependent disorder defined by ectopic endometrial-like tissue growth, persistent inflammation, and aberrant innervation. Emerging evidence indicates that disease progression and symptom severity are driven by a …

Published: May 19, 2026, midnight
Turning Challenges into Success: Successful Pregnancy in Advanced Maternal Age with Adenomyosis Using Prolonged GnRH Agonist Protocol: A Case Report.

Advanced maternal age (AMA) is a major challenge in reproductive medicine, compounded by coexisting conditions such as adenomyosis and endometriosis, which impair oocyte competence and endometrial receptivity. Prolonged gonadotropin-releasing hormone …

Published: May 19, 2026, midnight
An Unusual Diagnosis of Inguinal Pain in a Childbearing-Age Woman: An Inflamed Canal of Nuck Cyst With an Abnormal Leiomyomatous Proliferation.

The canal of Nuck cyst is a rare pathology seen in women in the inguinal canal. It is often mistaken for a hernia or a lipoma; however, diagnosis is confirmed …

Published: May 19, 2026, midnight
Ultrasound-Guided Diagnosis and Treatment of Postsurgical Peripheral Nerve Entrapment in Persistent Pelvic Pain.

Postsurgical peripheral neuropathic pain may be overlooked in patients with chronic pelvic and inguinal pain when overlapping etiologies coexist. This case report describes an ultrasound-guided diagnostic and therapeutic approach for …

Published: May 19, 2026, midnight
Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis - Contemporary OB/GYN

Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis Contemporary OB/GYN

Published: May 18, 2026, 8:17 p.m.
Merck ADC, licensed from China, hits mark in first big global trial - BioPharma Dive

Merck ADC, licensed from China, hits mark in first big global trial BioPharma Dive

Published: May 18, 2026, 4:03 p.m.
Merck, Kelun score with sac-TMT in endometrial cancer trial - Fierce Pharma

Merck, Kelun score with sac-TMT in endometrial cancer trial Fierce Pharma

Published: May 18, 2026, 3:21 p.m.
MSD's Sac-TMT delivers in first phase 3 readout - pharmaphorum

MSD's Sac-TMT delivers in first phase 3 readout pharmaphorum

Published: May 18, 2026, 3:17 p.m.
Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer - PharmaLive

Merck announces trial results for ADC that addresses unmet needs for patients with advanced endometrial cancer PharmaLive

Published: May 18, 2026, 1:38 p.m.
Expert Insights: Navigating the Influx of New Therapies in Endometrial Cancer - Pharmacy Times

Expert Insights: Navigating the Influx of New Therapies in Endometrial Cancer Pharmacy Times

Published: May 18, 2026, 1:08 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!